What is Intuitive Surgical Inc?
develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
ISRG · Verdict
Solid reward · low risk
ISRG stands out on balance sheet and cash flow, but watch the volatility signal.
Based on 88% data coverage
ISRG · Verdict
Current ratio 4.87
25% free-cash-flow margin
28% net margin · 17% ROE
Rev +17.4% CAGR · earnings +29.3%
Weak vs peers
P/E 47.8× · PEG 2.79
Model-based scoring. For information only — not financial advice.
develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 179.76B, and a P/E ratio of 64.5x.
The scoring profile indicates moderate reward potential, with profitability and growth as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.